Brent Weilert, MD
Pain Medicine · Fayetteville, ARNPI 1699828186
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,697 of the $2,788 with a category attached, or 60.9%. 3 manufacturers reported payments, led by Relievant Medsystems, Inc. at 59.1% of the total. Reporting peaked in 2023 at $1,699 and has fallen 91.8% since, to $139 in 2024. That places this record below the midpoint for pain medicine clinicians in AR, where the typical reported total is $3,271.
Across 92 payments — averaging $30.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$2K
- Medtronic$1000
- Boston Scientific$139
What the payments were for
- Travel & lodging$1,09039%
- Food & beverage$1,69761%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 14 | $1,649 |
| Medtronic(2 entities) | 75 | $1,000 |
| Boston Scientific | 3 | $139 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$5,076
How this compares
$2,788 in reported general payments places this provider in the 40th percentile of 53 pain medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 274 | $5,348 |
| Duloxetine Hcl | 51 | $1,810 |
| Pregabalin | 59 | $1,000 |
| Cyclobenzaprine Hcl | 67 | $557 |
| Celecoxib | 47 | $468 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $431 |
| Oxycodone Hcl | 17 | $370 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $305 |
| Meloxicam | 78 | $216 |
| Tizanidine Hcl | 20 | $215 |
| Ropinirole Hcl | 11 | $198 |
| Cephalexin | 38 | $177 |
| Tramadol Hcl | 18 | $122 |
| Diclofenac Sodium | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Fayetteville
- Mark MiedemaFayetteville$35K
- George DeimelFayetteville$26K
- Mary DautFayetteville$984
- William PiechalFayetteville$14
- Stephen PaulusLittle Rock$75K
- George ArcosConway$30K
- Julio OlayaLittle Rock$22K
- Maria Lyuksyutova-PriceMountain Home$19K
- Daniel JudkinsConway$17K
- Sheffield KentConway$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.